• Clinical Trial Site

Cerulea Clinical Trials is a recognised leader for ophthalmic clinical trials, serving both Australian and international biopharmaceutical companies, as well as investigator-initiated studies in collaboration with the Centre for Eye Research Australia (CERA).

Situated in the heart of Melbourne, we are dedicated to providing an exceptional clinical trial experience for participants, clinicians and sponsors; driving discoveries that have the potential to become transformative therapies in global markets. Our team can manage all aspects of eye clinical trials (Phase 1-IV); from design to publication and everything in between. We are experienced in all associated activities including study feasibilities, project management, monitoring, medical writing, biostatistics and safety management.

Our multidisciplinary team possess expertise in a wide array of eye diseases, including but not limited to age-related macular degeneration, glaucoma, uveitis, diabetic eye disease, corneal conditions, and retinal disorders.

With a focus on advanced therapeutics, such as gene and cell therapies, we are committed to providing Australians living with vision loss and blindness early access to cutting-edge treatments and finding better ways to help keep their sight.

We collaborate with research organisations, universities, pharmaceutical companies and biotech enterprises from all around the world. We are currently partnering with both Austin Hospital and St. Vincent’s Hospital on various clinical trials; whereby eye examinations and assessments are tailored to monitor potential adverse events that can arise from systemic trial medications.

We can provide coordination of an Eye Trials Research Network to expand access to private ophthalmology sites who may benefit from our training, certification and oversight.